Probiotics, recognized as beneficial and active microorganisms, often face challenges in maintaining their functionality under harsh conditions such as exposure to stomach acid and bile salts. In this investigation, we developed probiotic microcapsules and assessed their protective effects and underlying mechanisms in a murine model of dextran sulfate sodium (DSS)-induced colitis using male C57BL/6J mice. The administration of the probiotic microcapsules significantly mitigated body weight loss, prevented colon length shortening, decreased the disease activity index scores, and reduced histopathological scores in mice with DSS-induced colitis. Concurrently, the microencapsulated probiotics preserved intestinal barrier integrity by upregulating the expressions of tight junction proteins ZO-1 and occludin, as well as the mucus layer component MUC-2. Moreover, the treatment with probiotic microcapsules suppressed the activation of the NLRP3 inflammasome signaling pathway in the context of DSS-induced colitis. In conclusion, these findings support the utilization of probiotic microcapsules as a potential functional food ingredient to maintain the permeability of the intestinal barrier and alleviate colonic inflammation in UC.

This study presents a novel environmentally-friendly process for the selective extraction and enrichment of DHA/EPA-containing phospholipids (PL-DHA/EPA) from krill oil. The methodology leverages differential crystallization behavior between phospholipids and triacylglycerols in ethanolic solutions, exploiting their distinct freezing point thresholds to achieve precise fractionation. Response surface methodology optimization identified optimal extraction parameters: liquid-to-material ratio of 6:1 (v/w), freezing temperature of −20 °C, freezing duration of 25 h, and rotary evaporation temperature of 45 °C, yielding a final product with 39.40% PL-DHA/EPA content. Principal component analysis revealed substantial overlap in confidence ellipses among extraction methodologies, indicating effective preservation of core phospholipid signatures from the parent krill oil while maintaining critical structural characteristics and molecular species distribution. Comprehensive analysis of phospholipid fractions and heatmap analysis revealed distinctive molecular profiles compared to conventional organic solvent extraction, with selective enrichment of EPA-containing phospholipids, particularly PC-EPA and PI-EPA species. The green extraction method demonstrated comparable oxidative stability to conventional approaches, with superior protection against secondary oxidation as evidenced by significantly lower anisidine values. This sustainable approach achieves effective phospholipid enrichment while substantially reducing environmental impact through elimination of halogenated solvents, addressing the critical need for environmentally conscious technologies in marine lipid processing with potential applications in nutraceutical and functional food industries.

Royal jelly, a high-value natural product rich in bioactive compounds, is highly susceptible to quality deterioration during storage and processing. However, current quality standards rely predominantly on basic physicochemical parameters and measuring the content of 10-hydroxy-2-decenoic acid (10-HDA), which fail to capture the comprehensive and dynamic nature of its freshness. This significant knowledge gap hinders the accurate assessment, prediction, and control of royal jelly quality throughout its supply chain. To address this limitation, this review systematically elucidates the molecular mechanisms underlying the deterioration of royal jelly freshness, including key pathways such as protein denaturation, Maillard reactions, enzymatic inactivation, and lipid oxidation, and analyzes the combined effects of intrinsic and extrinsic factors on its quality stability. It highlights the potential applications of novel biochemical markers—including major royal jelly proteins (MRJPs), Maillard reaction products, enzymatic activity indicators, and energy metabolites—while comparing the advantages and limitations of traditional chromatographic techniques with modern rapid sensing and spectroscopic analysis methods. Regarding preservation, a critical yet inadequately summarized area, this review systematically evaluates the applicability and limitations of various approaches, including low-temperature storage, drying treatments, non-thermal sterilization, microencapsulation, and modified atmosphere packaging. Future directions for integrated quality control are outlined, providing a theoretical basis for holistic quality management of royal jelly.

Krill oil is effective in reducing blood lipid levels, particularly in individuals with severe hyperlipidemia. However, poor water insolubility and stability limited its usage. This study investigated a method for encapsulating Antarctic krill oil using alginate (ALG) and gelatin (GLN) to enhance its stability and bioactivity. The encapsulation efficiency, functional group integrity, swelling rate, and lipid-lowering activity were assessed. Results indicated that the optimal encapsulation conditions were identified with an ALG:GLN ratio of 2:1, coagulation bath of 9% CaCl₂, and a nozzle size of 750 μm, resulting in 69.34% encapsulation efficiency. Fourier-transform infrared spectroscopy confirmed successful encapsulation. The ALG-GLN shell materials enriched astaxanthin in krill oil and protected it from harsh gastric conditions, enabling targeted intestinal release. In a high-fat diet-induced rat model, krill oil microcapsules significantly reduced triglycerides (TG), total cholesterol (TC), and low-density lipoprotein (LDL) levels while increasing high-density lipoprotein (HDL) levels compared to unencapsulated krill oil. Additionally, the microcapsules elevated nitric oxide (NO) levels, enhanced superoxide dismutase (SOD) activity, and reduced malondialdehyde (MDA) levels, liver and perirenal fat weight. Therefore, encapsulating Antarctic krill oil in alginate-gelatin hydrogel offers a promising strategy for managing hyperlipidemia and associated metabolic disorders.

Antarctic krill oil (AKO) is a valuable nutraceutical; however, it is highly susceptible to oxidation. Encapsulation represents an effective strategy to enhance the storage stability of AKO. This study explored a novel approach for encapsulating AKO using sodium alginate (ALG) and gelatin (GLN) to improve its stability, and multiple parameters were systematically evaluated, including oil-loading efficiency, surface oil content, particle size, water activity, and thermal stability. Additionally, core-material retention efficiency, acid value, peroxide value, and anisidine value were measured after accelerated oxidation. The results demonstrated that the optimal encapsulation conditions consisted of an ALG:GLN ratio of 2:1, a 9% CaCl₂ coagulation bath, 750 μm nozzle size, followed by freeze-drying. Under these conditions, the microcapsules achieved an oil-loading efficiency of 62.63% and a surface oil content of 19.21%. The water activity of the microcapsules was 0.516. Thermogravimetric analysis indicated that AKO microcapsules encapsulated with ALG/GLN exhibited higher thermal stability (~300 °C) compared to those encapsulated with ALG alone (~280 °C). When AKO or its microcapsules were subjected to accelerated oxidation at 65 °C, compared to ALG-encapsulation alone, the ALG/GLN encapsulation system significantly reduced the oxidation indicators of the oil, such as acid value (24%), peroxide value (26%), and anisidine value (28%). In conclusion, incorporating GLN into ALG-based microcapsules significantly enhanced the antioxidant capacity of AKO and prolonged its shelf life.